Skip to main content
SpringerLink
Log in

Fettstoffwechsel, Übergewicht und Ernährung, Diabetes

  • Chapter
Klinische Kardiologie

  • 144 Accesses

Zusammenfassung

Fettstoffwechselstörungen gehören zu den häufigsten Stoffwechselerkrankungen der westlichen Hemisphäre. Sie sind durch die Erhöhung der Plasmakonzentrationen einer oder mehrerer Lipidkomponenten definiert. Die Hyperlipoproteinämien sind ein wichtiger Risikofaktor für die Entstehung der Atherosklerose, welche die pathoanatomische Grundlage für die Entstehung der koronaren Herzerkrankung, der peripheren arteriellen Verschlußerkrankung und der ischämischen zerebrovaskulären Krankheiten darstellt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur zu Sektion Kap. 14

  • Abbott RD, McGee D (1987) The Framingham Study, Section 37: The probability of developing certain cardiovascular diseases in eight years at specified values of some characteristics. Washington/DC (NIH publication No 87–2284 )

    Google Scholar 

  • Adams MR, Register TC, Golden DL, Wagner JD, Williams JK (1997) Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arteroscler Thromb Vasc Biol 17: 217–221

    CAS  Google Scholar 

  • Ahmed S, Howard M, Hove W ten, Regan TJ, Leevy CM (1984) Cardiac function in alcoholics with cirrhosis: absence of overt cardiomyopathy: myth or fact? J Am Coll Cardiol 3: 696–702

    PubMed  CAS  Google Scholar 

  • Alberti KGMM, Greis FA (1988) Management of non-insulin-dependent diabetes mellitus in Europe: a consensus view. Diab Med 5: 275–281

    CAS  Google Scholar 

  • Ailing C, Gustaysson L, Mansson JE, Benthin G, Anggard E (1984) Phosphatidyl-ethanol formation in rat organs after ethanol treatment. Biochim Biophys Acta 793: 119–122

    Google Scholar 

  • American College of Sports Medicine Position Stand (1993) Physical activity, physical fitness, and hypertension. Med Sci Sports Exerc 25: I-X

    Google Scholar 

  • American Diabetes Association (1993) Implications of diabetes control and complication trial. Position statement. Clin Diab 12: 91–96

    Google Scholar 

  • American Diabetes Association (1995) Consensus Statement: The pharmacological treatment of hyperglycemia in NIDDM. Diab Care 18: 1510–1518

    Google Scholar 

  • Amery A, Birkhäger J, Brixko P ( 1985, Mortality and morbidity results from the european working party on high blood pressure in the elderly trial. Lancet I: 1349–1354

    Google Scholar 

  • Anderson KM, Odell PM, Wilson PWF, Kannel WB (199o) Cardio-vascular disease risk profiles. Am Heart J 121: 293–298

    Google Scholar 

  • Anderson KM, Wilson PWF, Odell PM, Kannel WB (1991) An up-dated coronary risk profile. Circulation 83: 357–363

    Google Scholar 

  • Arkwright PD, Beilin LJ, Rouse IL, Armstrong BK, Vandongen R (1982) Effects of alcohol use and other apsects of lifesty on blood pressur levels and the prevalence of hypertension in a working population. Circulation 66: 6o - 66

    Google Scholar 

  • Arzneimittelkommission der Deutschen Ärzteschaft (1988) Empfehlungen zur Therapie der arteriellen Hypertonie. Arzneiverordnung in der Praxis, Sonderheft 9

    Google Scholar 

  • Assmann G (Stuttgart 1982 ) Lipidstoffwechsel and Atherosklerose. Schattauer, Stuttgart

    Google Scholar 

  • Assmann G, Schulte H (1992) The importance of triglycerides: results from the Prospective Cardiovascular Munster (PROCAM) Study. Eur J Epidemiol 1: 99–103

    Google Scholar 

  • Atkinson MA, MacLaren NK (1994)The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 331: 1428

    Google Scholar 

  • Ault A (1997) FDA issues warning on diet-drug combination. Lancet 350: 189

    Google Scholar 

  • Austin MA (1990) Plasma triglyceride and coronary heart disease. Arterioscler Thromb 11: 1–14

    Google Scholar 

  • Balica M, Boström K, Shin V, Tillisch K, Demer LL (1997) Calcifying subpopulation of bovin aortic smooth muscle cells is responsive to 17b-Estradiol. Circulation 95: 1954–1960

    PubMed  CAS  Google Scholar 

  • Barrett-Connor E, Grady D (1998) Hormone replacement therapy, heart disease, and other considerations.Annu Rev Public Health 19: 55–72

    CAS  Google Scholar 

  • Bartechi CE, MacKenzie TD, Schrier RW (1994) The human costs of tobacco use (first of two parts). N Engl J Med 330: 907–912

    Google Scholar 

  • Baysal K, Losordo DW (1996) Oestrogen receptors and cardiovascular disease. Clin Exp Pharmacol Physiol 23: 537–548

    PubMed  CAS  Google Scholar 

  • Beard CM, Griffin MR, Offord KP, Edwards WD (1986) Risk factors for sudden unexpected cardiac death in young women in Rochester, Minnesota, 1960 through 1974. Mayo Clin Proc 61: 186–191

    PubMed  CAS  Google Scholar 

  • Beisiegel U (1998) Lipoprotein metabolism. Eur Heart J 19 [Suppl A]: 20–23

    Google Scholar 

  • Berg K (1963) A new serum type system in man: the Lp system. Acta Pathol Microbiol Scand 59: 369–382

    PubMed  CAS  Google Scholar 

  • Björntorp B, Fahlen M, Grimby G et al. (1994) Carbohydrate and lipid metabolism in middle-aged, physically welltrained men. Metabolism 21: 1037–1044

    Google Scholar 

  • Blair SN, Kohl HW III, Barlow CE et al. (1995) Changes in physical fitness and all-cause mortality: a prospective study of healthy and unhealthy men. JAMA. 273: 1093–1098

    PubMed  CAS  Google Scholar 

  • Bloomgarden ZT (1998) Insulin resistance: Current concepts. Clin Ther 20 /2: 216–231

    PubMed  CAS  Google Scholar 

  • Bolinder G, Alfredsson L, Englund A, Faire U de (1994) Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health 84: 399–404

    PubMed  CAS  Google Scholar 

  • Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 274: 1049–1057

    PubMed  CAS  Google Scholar 

  • Brown S, Hutchinson R, Morrisett J et al. (1993) Plasma lipid, lipoprotein cholesterol and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities ( ARIC) Study. Arterioscler Thromb 13: 1139–1158

    Google Scholar 

  • Brunner D, Weisbort J, Meshulam N et al. (1987) Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: Twenty-year follow-up of the Donolo-Tel Aviv prospective coronary artery disease study. Am J Cardiol 59: 1271–1276

    Google Scholar 

  • Bulloch RT, Pearce MB, Murphy ML, Jenkins BJ, Davis JL (1972) Myocardial lesions in idiopathic and alcoholic cardiomyopathy. Study by ventricular septal biopsy. Am J Cardiol 29: 15–25

    Google Scholar 

  • Burch GE, Gilles TD (1971) Alcoholic cardiomyopathy: concept of the disease and its treatment: Am J Med 50: 141–145

    PubMed  CAS  Google Scholar 

  • Bush TL, Barrett-Connor E, Cowan LD et al. (1987) Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 75: 1102–1109

    PubMed  CAS  Google Scholar 

  • Cambridge Heart Antioxidant Study Group (CHAOS) (1996) Randomised trial of vitamin E in patients with coronary disease. Lancet 347: 781–786

    Google Scholar 

  • Cantin B, Gagnon F, Moorjani S et al. (1998) Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study. J Am Coll Cardiol 31: 519–525

    PubMed  CAS  Google Scholar 

  • Castelli WP, Anderson K (1986) A Population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framigham Study. Am J Med 8o [Suppl 2 A]: 23–32

    Google Scholar 

  • Castelli WP, Anderson K, Wilson PW, Levy D (1992) Lipids and risk of coronary heart disease: the Framingham Study. Ann Epide-miol 2: 23–28

    CAS  Google Scholar 

  • Cauley JA, Cummings SR, Black DM et al. (1990) Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gyneco1163: 1438–1444

    Google Scholar 

  • Cauley JA, La PR, Kuller LH et al. (1983) Menopausal estrogen use, high density lipoprotein cholesterol subfractions and liver function. Atherosclerosis 49: 31–39

    PubMed  CAS  Google Scholar 

  • Cohen EJ, Klatsky AL, Armstron MA (1988) Alcohol use and supra-ventricular arrhythmia. Am J Cardiol 62: 971–973

    PubMed  CAS  Google Scholar 

  • Colditz GA, Rimm EB, Giovannucci E et al. (1991) A prospective study of parental history of myocardial infarction and coronary artery disease in men. Am J Cardiol 67: 933–938

    PubMed  CAS  Google Scholar 

  • Colditz GA, Willett WC, Stampfer MJ et al. (1987) Menopause and the risk of coronary heart disease in women. N Eng J Med 316: 1105–1110

    CAS  Google Scholar 

  • Colditz GA, Willett WC, Stampfer MJ et al. (1987) Menopause and the risk of coronary heart disease in women. N Eng J Med. 316: 1105–1110

    CAS  Google Scholar 

  • Collins P, Beale CM, Rosano GMC (1996) Oestrogen as a calcium channel blocker. Eur Heart J 17 [Suppl D]: 27–31

    PubMed  CAS  Google Scholar 

  • Collins R, Peto R, Macmahon S et al. (1990) Blood pressure, stroke and coronary heart disease, part II: effects of short-term reduction of blood pressure–an overview of the unconfounded randomised drug trials in an epidemiological context. Lancet 335: 827–838

    PubMed  CAS  Google Scholar 

  • Consensus Panel Statement (1995) Comprehensive risk reduction for patients with coronary and other vascular disease. Circulation 92: 2–4

    Google Scholar 

  • Consensus Panel Statement (1997) Primary prevention of cardiovascular diseases. Circulation 95: 23–30

    Google Scholar 

  • Cook TC, Laporte RE, Washburn RA et al. (1986) Chronic low level physical activity as a determinant of high density lipoprotein cholesterol and subfractions. Med Sci Sports Exerc 18: 653–657

    PubMed  CAS  Google Scholar 

  • Cremer P, Nagel D, Labrot B et al. (1994) Lipoprotein(a) as a predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: Result from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS) Eur J Clin Invest 24: 444–453

    Google Scholar 

  • Criosjank JM (1992) Beta-blockers: primary and secondary prevention. J Cardiovasc Pharmacol [Suppl 11]: S65 - S69

    Google Scholar 

  • Criqui MH, Wallace RB, Mishkel M et al. (1981) Alcohol consumption and blood pressure: the Lipid Research Clinics Prevalence Study. Hypertension 3: 557–565

    PubMed  CAS  Google Scholar 

  • Cullen P, Eckardstein A von, Assmann G (1998) Diagnosis and management of new cardiovascular risk factors. Eur Heart J 19 [Suppl 0]: 013–019

    Google Scholar 

  • Dahlöf B, Lindholm LDG, Hanson L et al. (1991) Morbidity and mortality in the swedish trial in old patients with hypertension ( STOP hypertension ). Lancet 338: 1281–1285

    Google Scholar 

  • Danish Study Group on Verapamil in Myocardial Infarction (1990) Secondary prevention with verapamil after myocardial infarction. Am J Cardiol 66: 331–401

    Google Scholar 

  • Dawber TR (1980) The Framingham Study. The epidemiology of atherosclerotic disease. Harvard University Press, Cambridge/ MA

    Google Scholar 

  • DeBusk RF, Stenestrand U, Sheehan M, Haskell WL (1990) Training effects of long vs. short bouts of exercise in healthy subjects. Am J Cardiol 65: 1010–1013

    PubMed  CAS  Google Scholar 

  • Delmas PC, Bjarnason NH, Mitlak BH et al. (1997) Effects on raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 337: 1641–1647

    PubMed  CAS  Google Scholar 

  • Demakis TG, Proskey A, Rahimtoola SH et al. (1974) The natural course of alcoholic cardiomyopathy. Ann Intern Med 80: 293–292

    PubMed  CAS  Google Scholar 

  • Denollet J, Sys SU, Stroobant N et al. (1996) Personality as independent predictor of long term mortality in patients with coronary heart disease. Lancet 347: 417–421

    PubMed  CAS  Google Scholar 

  • Desmarais RL, Sarembock IJ, Ayers CR et al. (1995) Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after balloon coronary angioplasty. Circulation 91: 1403–1409

    PubMed  CAS  Google Scholar 

  • Deutsche Liga zur Bekämpfung des hohen Blutdruckes e.V.Deutsche Hypertoniegesellschaft (1999) Empfehlungen zur Bluthochdruckbehandlung.Verlautbarungen der Deutschen Hypertoniegesellschaft, Heidelberg

    Google Scholar 

  • Donahu RP, Abbott RD, Reed DM, Yano K (1986) Alcohol and hemorrhagic stroke: the Honolulu heart program. JAMA 255: 2310–2314

    Google Scholar 

  • Durnstine JL, Haskell WL (1994) Effects of exercise training on plasma lipids and lipoproteins. Exerc Sport Sci Rev 22: 477–521

    Google Scholar 

  • Dwyer JH (1997) Exposure to environmental tobacco smoke and coronary risk. Circulation 96: 1403–1414

    Google Scholar 

  • Dyer AR (1974) An analysis of the relationship of systolic blood pressur, serum cholesterol, and smoking to 14 year mortality in the Chicago People’s Gas Company Study. J Chron Dis 28: 571–578

    Google Scholar 

  • Epstein FH, Francis T, Hayner NS et al. (1965) Prevalence of chronic disease and distribution of selected physiologic variables in a total community, Tecumseh, Michigan. Am J Epidemiol 81: 307–322

    Google Scholar 

  • Epstein SE, Speir E, Zhou YF et al. (1996) The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus. Lancet 348: 13–19

    Google Scholar 

  • Eriksson H, Svärdsudd K, Larsson B et al. (1989) Risk factors for heart failure in the general population: The study of men born in 1923. Eur Heart J lo: 647–656

    Google Scholar 

  • Erkkola R, Lammintausta R, Punnonen R, Rauramo L (1978) The effect of estradiol succinate therapy on plasma renin activity and urinary aldosterone in postmenopausal women. Maturitas 1: 9–14

    PubMed  CAS  Google Scholar 

  • Ernst E, Hammerschmidt DE, Bagge U et al. (1987) Leukozyte and the risk of ischemic diseases. JAMA 257: 2318–2324

    PubMed  CAS  Google Scholar 

  • Ernst E, Koenig W (1997) Fibrinogen and cardiovascular risk. Vasc Med 2: 115–125

    PubMed  CAS  Google Scholar 

  • Ernst E, Resch KL (1993) Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 12: 956–963

    Google Scholar 

  • Espeland MA, Marcovina SM, Miller V et al. for the PEPI Investigators (1998) Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. Circulation 97: 979–986

    Google Scholar 

  • Estaccio RO, Jeffers BW, Hiatt WR et al. (1998) The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 338: 645–652

    Google Scholar 

  • Ettinger PO, Wu CF, DeLaCruz C et al. (1978) Arrythmias and the „holiday heart“: Alcohol-associated cardiac rhythm disorders. Am Heart J 95: 555

    Google Scholar 

  • EuroAspire Study Group (1997) A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. European action on secondary prevention through intervention to reduce events. Eur Heart 118: 1569–1592

    Google Scholar 

  • European IDDM/NIDDM Policy Group (1998) Richtlinien zur Behandlung des Diabetes mellitus. http://www.uni-giessen.de/ diabetes

    Google Scholar 

  • European Society of Cardiology, European Atherosclerosis Society, European Society of Hypertension, International Society of Behavioural Medicine, European Society of General Practice/ Family Medicine, European Heart Network (1998) Prevention of coronary heart disease in clinical practice. Recommendations of the second joint task force of European and other societies on coronary prevention. Eur Heart J 19: 1434–1503

    Google Scholar 

  • Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (1993) Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 269: 3015–3023

    Google Scholar 

  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (1994) National Cholesterol Education Program: Second report of the expert panel of detection, evaluation, and treatment of high blood cholesterol (Adult Treatment Panel II). Circulation 89: 1329–1445

    Google Scholar 

  • Fabrizio L, Regan T (1994) Alcoholic cardiomyopathy. Cardiovasc Drugs Ther 8: 89–94

    Google Scholar 

  • Faggiotto A, Ross R (1984b) Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis 4: 341

    Google Scholar 

  • Faggiotto A, Ross R, Harker L (1984a) Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streaks formation. Arteriosclerosis 4: 323

    Google Scholar 

  • Ferrannini E, Haffner SM, Stern MP (5990) Insulin sensitivity and hyperension. J Hypertens 8 [Suppl II]: II-3-II-7

    Google Scholar 

  • Feskens EJM, Loeber JG, Kromhout D (1994) Diet and physical activity as determinants of hyperinsulinemia: The Zutphen Elderly Study. Am J Epidemiol 140: 350–360

    Google Scholar 

  • FitzGerald GA, Oates JA, Nowak J (1988) Cigarette smoking an hemostatic function. Am Heart J 115: 257–271

    Google Scholar 

  • Flesch M, Erdmann E, Böhm M (1998) Alkohol and Myokardinfarkt–Epidemiologische and experimentelle Untersuchungen zum Einfluß von Alkohol auf Gefäßrelaxation and Koronarsklerose. Dtsch Med Wochenschr 123: 1490–1496

    PubMed  CAS  Google Scholar 

  • Fletscher GF (1997) How to implement physical activity in primary and secondary prevention. Circulation 96: 355–357

    Google Scholar 

  • Fletscher GF, Balady G, Blair SN et al. (5996) Statement on exercise: Benefits and recommendations for physical activity for all Americans. Circulation 94: 857–862

    Google Scholar 

  • Folsom AR, Nieto FJ, Mc Govern PG et al. (1998) Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the atherosclerosis risk in communities ( ARIC) study. Circulation 98: 204–210

    Google Scholar 

  • Folsom AR, Wu KK, Davis CE et al. (5991) Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 91: 191–205

    Google Scholar 

  • Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE (1997) Prospective study of hemostatic factors and incidence of coronary heart disease. The ARIC Study. Circulation 96: 1102–1108

    Google Scholar 

  • Fortmann SP, Marcovina SM (1997) Lipoprotein(a), a clinically elusive lipoprotein particle. Circulation 95: 295–296

    PubMed  CAS  Google Scholar 

  • Francis GS, Johson TH, Ziesche S et al. (1990) Marked spontaneous improvement in ejection fraction in patients with congestive heart failure. Am J Med 89: 303–307

    PubMed  CAS  Google Scholar 

  • Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 488–502

    Google Scholar 

  • Friedman JM, Halaas JL (1998) Leptin and the regulation of body weight in mammals. Science 395: 763–770

    CAS  Google Scholar 

  • Fuchs CS, Stampfer MJ, Colditz GA et al. (1995) Alcohol consumpti- on and mortality among women. N Engl J Med 332: 1245–1250

    PubMed  CAS  Google Scholar 

  • Fuster V, Badimon L, Badimon JJ, Chesboro JH (1992) The pathogenesis of coronory artery disease and the acute coronary syndromes. N Engl J Med 326: 242–250, 310–318

    Google Scholar 

  • Fuster V, Gersh BJ, Giuliani ER et al. (1981) The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 47: 525–531

    Google Scholar 

  • Garcia-Palmeri MR, Costa R (1986) Risk factors of coronary heart disease: a progressive study in Puerto Rico. In: Yu PH, Goodwin FH (eds) Progress in cardiology. Lea and Febiger, Philadelphia, pp 101–190

    Google Scholar 

  • Ghosh S, Schork NJ (1996) Genetic analysis of NIDDM. The study of quantitative traits. Diabetes 45: 1

    Google Scholar 

  • Gill JS, Zezulka AV, Shipley MJ et al. (1986) Stroke and alcohol consumption. N Engl J Med 315: 1041–1046

    PubMed  CAS  Google Scholar 

  • Gordon T, Kannel WB (1983) Drinking and its relation to smoking, BP, blood lipids and uric acid. Arch Intern Med 143: 1366–1374

    Google Scholar 

  • Grady D, Rubin SM, Petitti DB et al. (1992) Hormone therapy to pre-vent disease and prolong life in postmenopausal women. Ann Intern Med 117: 1016–1037

    PubMed  CAS  Google Scholar 

  • Grainger DJ, Kirschenlohr IIL, Metcalfe JC et al. (1993) Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science 260: 1655–1658

    PubMed  CAS  Google Scholar 

  • Green A, Gale EAM, Patterson CC (1992) Incidence of childhood-onset insulin dependent diabetes mellitus: the EuroDiab ACE study. Lancet 339: 905–909

    Google Scholar 

  • Greten H (1976) Lipoprotein metabolism. Springer, Berlin Heidelberg New York Tokio

    Google Scholar 

  • Greten H (1992) Richtlinien der Kommission für klinische Kardiologic der DGK/IIKF. Dtsch Arzteblatt 89/1/2: 37–38

    Google Scholar 

  • Grodstein F, Stampfer MJ, Mason JE et al. (1996) Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 335: 453–461

    PubMed  CAS  Google Scholar 

  • Grossman E, Messerli F (1996) Diabetic and hypertensive disease. Ann Intern Med 1z5: 304–310

    Google Scholar 

  • Grundy SM, Balady GJ, Criqui MH et al. (1997) When to start cholesterol-lowering therapy in patients with coronary heart disease: a statement for health care professionals from the American Heart Association Task Force on Risk Reduction. Circulation 95: 1683–1685

    PubMed  CAS  Google Scholar 

  • Gupta S, Leatham EW (1997) The relation between Chlamydia pneumoniae and atherosclerosis. Heart 77: 7–8

    PubMed  CAS  Google Scholar 

  • Gurakar A, Hoeg JM, Kostner G et al. (1985) Levels of Lipoprotein Lp(a) decline with neomycin and niacin treatment. Atherosclerosis 57: 293–301

    PubMed  CAS  Google Scholar 

  • Gurr M, James AT (1975) Lipid biochemistry an introduction. Chapman and Hall, London

    Google Scholar 

  • Hagberg JM, Brown MD (1995) Does exercise training play a role in the treatment of essential hypertension? J Cardiovasc Risk 2: 296–302

    PubMed  CAS  Google Scholar 

  • Hahn RA, Teutsch SM, Rothenberg RB, Marks JS (1986) Excess deaths from nine chronic diseases in the United States. JAMA 264: 2654–2659

    Google Scholar 

  • Hajjar DP, Haberland ME (1997) Lipoprotein trafficking in vascular cells. Molecular Trojan horses and cellular saboteurs. J Biol Chem 272/37: 22.975–22. 978

    Google Scholar 

  • Haller H, Hanfeld M, Jaroß W (1975) Lipidstoffwechselstörungen. Diagnostik, Klinik and Therapie. Fischer, Jena

    Google Scholar 

  • Hamsten A, Walldius G, Szamose A et al. (1987) Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet II: 3–9

    Google Scholar 

  • Hamsten A, Wiman B, Faire U de, Blomback M (1985) Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313: 1557–1563

    Google Scholar 

  • Hansson L, Zancchetti A, Carruthers SG et al. for The Hot Study Group (1998) Effect of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principle results of the hypertension optimal treatment ( HOT) randomised trial. Lancet 351: 1755–1762

    Google Scholar 

  • Hansson L, Zanchetti A, Carruthers SG et al. (1998) Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomise trial. HOT Study Group. Lancet 351 (9118): 1755–1762

    PubMed  CAS  Google Scholar 

  • Hardman AE (1996) Exercise in the prevention of atherosclerotic, metabolic and hypertensive diseases: A review. J Sports Sci 14: 201–218

    PubMed  CAS  Google Scholar 

  • Harris MI (1993) Undiagnosed NIDDM: clinical and public health issues. Diab Care 16: 542–652

    Google Scholar 

  • Harris T, Cook EF, Garrison R et al. (1988) Body mass index and mortality among nonsmoking older persons. The Framingham Heart Study. JAMA 259: 152o - 1524

    Google Scholar 

  • Haskell WL (1991) Dose-response relationships between physical activity and disease risk factors. In: Oja P, Telama R (eds) Sport for all. Elsevier, Amsterdam, pp 125–133

    Google Scholar 

  • Hassager C, Rus BJ, Strom V, Guyene TT, Christiansen C (1987) The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure. Circulation 76: 753–758

    PubMed  CAS  Google Scholar 

  • Hasslacher C, Kempe HP, Bostedt-Kiesel A (1993) ACE inhibitors and diabetic nephropathy: clinical and experimental findings. Clin Invest Med 71/5: 20–24

    Google Scholar 

  • Hauer H (1998) Verbreitung des Diabets mellitus in Deutschland. Dtsch Med Wochenschr 123: 777–782

    Google Scholar 

  • Heckbert SR, Weiss NS, Koepsell TD et al. (1997) Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women. Arch Intern Med 157: 1330–1336

    PubMed  CAS  Google Scholar 

  • I-Ielmrich SP, Ragland DS, Leung RW, Paffenbarger RS (1991) Physical activity and reduced occurence of non-insulin-dependent diabetes mellitus. N Engl J Med 325: 147–152

    Google Scholar 

  • Henderson BE, Panganini-Hill A, Ross RK (1991) Decreased mortality in users of estrogen replacement therapy. Arch Intern Med 151: 75–78

    Google Scholar 

  • Hibbs RG, Ferrans VJ, Black WC et al. (1965) Alcoholic cardiomyo-pathy. An electron microscopic study. Am Heart J 69: 766–779

    Google Scholar 

  • Hillbom M (1987) What supports the role of alcohol as a risk factor for stroke? Acta Med Scand 17 [Suppl 7]: 93–106

    Google Scholar 

  • Hillsdon M, Thorogood M, Anstiss T, Morris J (1995) Randomized controlled trials of physical activity promotion in free living populations: a review. J Epidemiol Community Health 49: 448–453

    Google Scholar 

  • Ho KK, Pinsky JL, Kannel WB, Levy D (1993) The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 22: 6A - 13A

    Google Scholar 

  • Hodis HN, Mack WJ (1995) Triglyceride rich lipoproteins and the progression of coronary artery disease. Curr Opin Lipidol 6: 209–214

    Google Scholar 

  • Hodis HN, Mack WJ, Azen SP et al. (1994) Triglyceride-and cholesterol-rich lipoproteins have a differential effect on mild/ moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation 90: 42–49

    Google Scholar 

  • Hokanson JE, Austin MA (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3: 213–219

    PubMed  CAS  Google Scholar 

  • Hong MK, Romm PA, Reagan K, Green CE, Rackley CE (1992) Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women [see comments]. Am J Cardiol 69: 176–178

    PubMed  CAS  Google Scholar 

  • Hoppe UC, Beuckelmann DJ, Erdmann E (1997) Bei welchen Antihypertensiva ist eine Reduktion von Letaliät oder Morbidität gesichert? Herz Kreisl 29: 202–206

    Google Scholar 

  • Houston MC (1992) New sights and approaches to reduce end-organ damage in the treatment of hypertension: Subsets of hypertension approach. Am Heart J 123: 1337–1367

    PubMed  CAS  Google Scholar 

  • Hulley S, Grady D, Bush T et al. for the Heart and Estrogen/ progestin Replacement Study (HERS) Research Group (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 28o: 605–613

    Google Scholar 

  • ISIS-4 Collaborative Group (1991) Fourth International Study of Infarct Survival. Protocol for a large simple study of the effects of oral mononitrate, of oral captopril, and of intravenous magnesium. Am J Cardiol 68: 87D - 100D.

    Google Scholar 

  • Israel Y, Hurwitz E, Niemelä O, Arnon R (1986) Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts. Proc Natl Acad Sci USA 83: 7923–7927

    PubMed  CAS  Google Scholar 

  • Jackson RL, Gotto AM Jr (1976) Hypothesis concerning membrane structure, cholesterol, and atherosclerosis. In: Paoletti R, Gotto AM Jr (eds) Atherosclerosis Reviews, vol 1. Raven Press, New York, p 1

    Google Scholar 

  • Jacobsen DW, Gatautis VJ, Green R et al. (1994) Rapid HPLC determination of total homoysteine and other thiols in serum and plasma: sex difference and correlation with cobalamin and folate levels in normal subjects. Clin Chem 40: 873–881

    PubMed  CAS  Google Scholar 

  • Jialal I (1998) Solving lipoprotein risk factors: lipoprotein(a) and oxidized low-density lipoprotein. Clin Chem 44: 1827–1831

    PubMed  CAS  Google Scholar 

  • Joint National Committee on Prevention D (1997) Evaluation and treatment of high blood pressure (INC VI): The Sixth Report of the National Institutes of Health, National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program. Washington/DC (NIH Publication No. 98–4080 )

    Google Scholar 

  • Juhan-Vague I, Alessi MV (1998) PAI-1 and the risk of cardiovascular disease. In: Gotto AM, Lenfant C, Paoletti R, Catapano AL, Jackson AS (eds) Multiple risk factors in cardiovascular disease. Kluwer, Dordrecht, pp 85–92

    Google Scholar 

  • Juhan-Vague I, Pyke SDM, Alessi MC et al. (1996) Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation 94: 2057–2063

    PubMed  CAS  Google Scholar 

  • Kaffarik H, Schneider J (Hrsg) (1984) Hyperlipoproteinämie. Pa- thophysiologie, Diagnostik, Therapie. Perimed, Erlangen

    Google Scholar 

  • Kagan A, Harris BR, Winkelstein W (1974) Epidemiologic studies of coronary disease and stroke in Japanese men livin in Japan, Hawaii, and California: Demographic, physical, dietary and biochemical characteristics. J Chron Dis 27: 345–364

    Google Scholar 

  • Kannel WB (1995) Range of serum cholesterol values in the population developing coronary heart disease. Am J Cardiol 76: 69C–77C

    Google Scholar 

  • Kannel WB, Castelli WP, Gordon T, McNamara PM (1971) Serum cholesterol, lipoproteins, and the risk of coronary heart disease: the Framingham Study. Ann Intern Med 74: 1–12

    PubMed  CAS  Google Scholar 

  • Kannel WB, Castelli WP, McNamara PM et al. (1972) Role of blood pressure in the development of congestive heart failure: the Framingham study. N Engl J Med 287: 781–787

    PubMed  CAS  Google Scholar 

  • Kannel WB, Cupples A (1988) Epidemiology and risk profile of cardiac failure. Cardiovasc Drugs Ther 2 [Stipp’ I]: 387–395

    Google Scholar 

  • Kannel WB, Doyle JT, Ostfeld AM et al. (1984) Optional resources for primary prevention of athersclerotic diseases (Atherosclerosis Study Group). Circulation 7o: 155A-2o5A

    Google Scholar 

  • Kannel WB, Levy G, Cupples GA (1987) Left ventricular hypertrophy and risk of cardiac failure: Insights from the Framingham Study. J Cardiovasc Pharmacol 10 [Supp16]: S135 - S14o

    PubMed  Google Scholar 

  • Kannel WB, Soli WP (1981) Left ventricular hypertrophy in hypertension. Prognostic and pathogenetic implications: The Framingham Study. In: Strauer BE (ed) The heart in hypertension. Springer, Berlin Heidelberg New York Tokio, pp 223–242

    Google Scholar 

  • Kannel WB, Wilson PF, Zhang TJ (1991) The epidemiology of impaired glucose tolerance and hypertension. Am Heart J 121: 1268–1273

    PubMed  CAS  Google Scholar 

  • Kannel WB, Wolf PA, Verter J, McNamara PM (1970) Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA 214: 301–310

    Google Scholar 

  • Kappel C, Dillis DG (1998) Type 2 Diabetes: Update on therapy. Comp Ther 24 (6/7): 319–326

    CAS  Google Scholar 

  • Katz AM (1990) Cardiomyopathy of overload. N Engl J Med 322: 100–110

    PubMed  CAS  Google Scholar 

  • Kawachi J, Colditz GA, Stampfer MJ et al. (1993) Smoking cessation in relation to total mortality in women. Ann Intern Med 119: 992–1000

    Google Scholar 

  • Keys A (ed) (1980) Seven countries. A multivariate analysis of death and coronary heart disease. Harvard University Press, Cambridge/MA

    Google Scholar 

  • Kinney EL, Wright RJ, Caldwell JW (1989) Risk factors in alcoholic cardiomyopathy. Angiology 40: 270

    PubMed  CAS  Google Scholar 

  • Klatsky AL, Friedman GD, Siegeland AB, Gerard MJ (1977) Alcohol consumption and blood pressure. N Engl J Med 296: 1194–1200

    PubMed  CAS  Google Scholar 

  • Koenig W (1998) Haemostatic risk factors for cardiovascular diseases. Eur Heart J 19 [Suppl C]: C39–C43

    Google Scholar 

  • Konsensus-Bericht der European IDDM Policy Group 1993 (1994) Teil 1: Richtlinien für die Behandlung des Typ-I-Diabetes (insulinabhängigen Diabetes mellitus). Diab Stoffw 3: 436–440

    Google Scholar 

  • Konsensus-Bericht der European IDDM Policy Group 1993 (1995) Teil 2:Richtlinien für die Behandlung des Typ-I-Diabetes (insulinabhängigen Diabetes mellitus). Diab Stoffw 4:30–35

    Google Scholar 

  • Konsensus-Bericht der European IDDM Policy Group 1993 (1995) Teil 3: Richtlinien für die Behandlung des Typ-I-Diabetes (insulinabhängigen Diabetes mellitus). Diab Stoffw 4: 95–98

    Google Scholar 

  • Konsensus-Bericht der European IDDM Policy Group 1993 (1995) Teil 4: Richtlinien für die Behandlung des Typ-I-Diabetes (insulinabhängigen Diabetes mellitus). Diab Stoffw 4:334–335

    Google Scholar 

  • Kramer K, Culler L, Fisher R (1968) The increasing mortality attributed to cirrhosis and fatty liver in Baltimore (1957–1966). Ann Intern Med 69: 273–282

    PubMed  CAS  Google Scholar 

  • Krieger M (1998) The „best“ of cholesterols, the „worst” of cholesterols: a tale of two receptors. Proc Natl Acad Sci USA 95/8: 4077–4080

    Google Scholar 

  • Kronenberg F, Steinmetz A, Kostner G, Dieplinger H (1996) Lipoprotein(a) in health and disease. Crit Rev Clin Lab Sci 33: 495–543

    Google Scholar 

  • Krotkiewski M (1990) Can body fat patterning be changed? Acta Medica Scandinavica [Suppl] 723: 213–223

    Google Scholar 

  • Kuiper GGJM, Gustafsson JA (1997) The novel estrogen receptor-[3 subtype: potential role in the cell-and promoter-specific actions of estrogens and anti-estrogens. Federation of European Biochemical Societies 410: 87–90

    CAS  Google Scholar 

  • Kuller LH, Evans RW (1998) Homocysteine, vitamins, and cardiovascular disease. Circulation 98: 196–199

    PubMed  CAS  Google Scholar 

  • Kupari M, Koskinen E Suokas A, Ventila M (1990) Left ventricular filling impairment in asymptomatic chronic alcoholics. Am J Ca rdiol 66: 1473–1477

    CAS  Google Scholar 

  • Kushi LH, Folsom AR, Prineas RJ et al. (1996) Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 334: 1156–1162

    PubMed  CAS  Google Scholar 

  • Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu J, Bostik RM (1996) Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 334: 1156–1162

    PubMed  CAS  Google Scholar 

  • Lapasota EA, Lange LG (1986) Presence of nonoxidative ethanol metabolism in human organs commonly damaged by ethanol abuse. Science 231: 497–499

    Google Scholar 

  • Larsson B, Bengtsson C, Bjorntorp P et al. (1992) Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women. Am J Epidemiol 135: 266–273

    PubMed  CAS  Google Scholar 

  • Laufs U (1996) „Fettfreies Fett Olestra“ in den USA zugelassen. Dtsch Ärzteblatt 93/6: 213

    Google Scholar 

  • Laufs U, La Fata V, Liao JK (1997) Inhibition of 3-hydroxy-3-methylglutaryl (HMG) CoA reductase blocks hypoxia-mediated down-regulation of endothelial nitric oxide synthase. J Biol Chem 272/50: 31.730–31. 735

    Google Scholar 

  • Laufs U, La Fata V, Plutzky J, Liao JK (1998) Upregulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors. Circulation 97: 1129–1135

    PubMed  CAS  Google Scholar 

  • Laufs U, Böhm M (2000) Kardiovaskulärer Risikofaktor Adiposi-tas. Dtsch med. Wochenschr 125: 262–268

    Google Scholar 

  • Law M, Tang JL (1995) An analysis of the effectiveness of interventions intended to help people to stop smoking. Arch Int Med 155: 1933–1941

    CAS  Google Scholar 

  • Lawn RM (1991) The structure and evolution of apolipoprotein(a) Ann Intern Med 115: 209–218

    Google Scholar 

  • Lee IM, Hsieh CC, Paffenbarger RS Jr (1995) Exercise intensity and longevity in men: the Harvard Alumni Health Study. JAMA 273: 179–1184

    Google Scholar 

  • Leibel RL, Rosenbaum M, Hirsch J (1995) Changes in energy expenditure resulting from altered body weight. N Engl J Med 332: 621–628

    PubMed  CAS  Google Scholar 

  • Levine JA, Eberhardt NL, Jensen MD (1999) Role of nonexercise activity thermogenesis in resistance to fat gain in humans. Science 283: 212–214

    PubMed  CAS  Google Scholar 

  • Levine JA, Jensen MD, Eberhardt NL, O’Brien T (1998) Adipocyte macrophage colony-timulating factor is a mediator of adipose tissue growth. J Clin Invest 101: 1557–1564

    Google Scholar 

  • Levy D, Evy D, Garrison RJ et al. (1990) Prognostic implications of echocardiographically, determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322: 1561–1566

    PubMed  CAS  Google Scholar 

  • Lipid Research Clinics (1980) Population studies data book [Abstract]

    Google Scholar 

  • Liu AC, Lawn RM (1994) Vascular interaction of lipoprotein(a). Curr Opin Lipidol 5: 269–273

    Google Scholar 

  • Lowenstein SR, Gabow PA, Cramer J et al. (1983) The role of alcohol in new-onset atrial fibrillation. Arch Intern Med 143: 1882–1885

    PubMed  CAS  Google Scholar 

  • Mac Mahon S (1994) Blood pressure and the risk of cardiovascular disease. In: Swales JD (ed) Textbook of hypertension. Blackwell, Oxford, pp 46–60

    Google Scholar 

  • MacKenzie TD, Bartechi CE, Schrier RW (1994) The human costs of tobacco use (second of two parts). N Engl J Med 330: 975–980

    PubMed  CAS  Google Scholar 

  • MacMahon S, Peto R, Cutler J et al. (1990) Blood pressure, stroke and coronary heart disease, part I: effects of prolonged differences in blood pressure - evidence from nine prospective observational studies corrected for the regression dilution bias. Lancet 335: 765–774

    Google Scholar 

  • MacMahon S, Sharpe N (1991) The J-curve phenomenon and the treatment of hypertension. JAMA 266: 64–65

    Google Scholar 

  • Mahler VMG, Brown BG, Marcovina SM et al. (1995) Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a). JAMA 274: 1771–1774

    Google Scholar 

  • Manson JE, Willett WC, Stampfer MJ et al. (1995) Body weight and mortality among women. N Engl J Med 333: 677–685

    PubMed  CAS  Google Scholar 

  • Marmot MG, Ross G, Shipley MJ, Thomas BJ (1981) Alcohol and mortality: a U-shaped curve. Lancet I: 580–583

    Google Scholar 

  • Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D (1986) Serum cholesterol, blood pressure and mortality: implications from a cohort of 361.662 men. Lancet II: 933–936

    Google Scholar 

  • Mayer BD, Peters AL (1997) An overview of metformin in the treat-ment of type 2 diabetes mellitus. Am J Med sot: 99–110

    Google Scholar 

  • McGinnis JM, Fiege WH (1993) Actual causes of death in the United States. JAMA 270: 2207–2212

    Google Scholar 

  • McLean JW, Tomlinson JE, Kuang W-J et al. (1987) cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 330: 132–137

    Google Scholar 

  • Meade TW, Mellows S, Brozovic M et al. (1986) Haemostatic function and ischemic heart disease: principal results of the Northwick Park Heart Study. Lancet II: 533–537

    Google Scholar 

  • Mehnert H (1998) Metformin in der Diabetestherapie. Internist 39: 222–228

    PubMed  CAS  Google Scholar 

  • Minick CR, Fabricant CG, Fabricant J, Litrenta MM (1979) Atheroarteriosclerosis induced by infection with a herpesvirus. Am J Pathol 96: 673–706

    PubMed  CAS  Google Scholar 

  • Mittleman MA, Maclure M, Tofler GH et al. (1993) Triggering of acute myocardial infarction by heavy physical exertion: protection against triggering by regular exertion. N Engl J Med 329: 1677–1683

    Google Scholar 

  • Molitch ME (1994) ACE inhibitors and diabetic nephropathy. Diabetes Care 17 /7: 756–760

    PubMed  CAS  Google Scholar 

  • Moser M, Hebert PR (1996) Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 27: 1214–1218

    PubMed  CAS  Google Scholar 

  • MRC Working Party (1992) Medical research council trial of treatment of hypertension in older adults: principal results. Br Med 1304:405–412

    Google Scholar 

  • Murray LJ, Bamford KB, O’Reilly DPJ et al. (1995) Helicobacter pylori infection: relation with cardiovascular risk factors, ischaemic heart disease, and social class. Br Heart J 74: 497–501

    Google Scholar 

  • Nabulsi AA, Folsom AR, White A et al. (1993) Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study. N Engl J Med 328: 1069–1075

    Google Scholar 

  • Nachmann RL (1992) Thrombosis and atherogenesis: Molecular Connection. Blood 79: 1897–1906

    Google Scholar 

  • National Cholesterol Education Program (1991) Report of the expert panel on population strategies for blood cholesterol reduction. Circulation 83: 2154–2232

    Google Scholar 

  • National Cholesterol Education Program (1994) Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II) Circulation 89: 1333–1445

    Google Scholar 

  • National Heart, L., And Blood Institute (1996) Morbidity and mortality: 1996 chartbook on cardiovascular lung and blood diseases. [Abstract]

    Google Scholar 

  • Negri E, Franzosi MG, La Vecchia C et al. (1993) Tar yield of cigarettes and risk of acute myocardial infarction. Br Med J 306: 1567–1570

    Google Scholar 

  • Newton KM, La Croix AZ, McKnight B et al. (1997) Estrogen replacement therapy and prognosis after first myocardial infarction. Am J Epidemiol 145 /3: 269–277

    PubMed  CAS  Google Scholar 

  • Nickenig G, Bäumer ATS, Grohe S et al. (1998) Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 97: 2197–2201

    PubMed  CAS  Google Scholar 

  • Nickenig G, Sachinidis A, Michaelsen F et al. (1997) Up-regulation of vascular angiotensin II receptor gene expression by low densitiy lipoprotein in vascular smooth muscle cells. Circulation 95: 473–478

    Google Scholar 

  • Niebauer J, Hambrecht R, Velich T et al. (1997) Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention. Circulation 96: 2534–2541

    PubMed  CAS  Google Scholar 

  • Nordestgaard BG (1996) The vascular endothelial barrier–selecti-ve retention of lipoproteins. Curr Opin Lipidol 7: 269–273

    PubMed  CAS  Google Scholar 

  • O’Brien JE, Peterson ED, Keeler GP et al. (1996) Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions. J Am Coll Cardiol 28: 1111–1118

    PubMed  Google Scholar 

  • O’Connor GT, Boring JE, Yusuf S et al. (1989) An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 80: 234–244

    PubMed  Google Scholar 

  • O’Keefe JH, Kim SC, Hall RR et al. (1997) Estrogen replacement therapy after coronary angioplasty in women. J Am Coll Cardiol 29: 1–5

    PubMed  Google Scholar 

  • O’Leary DH, Polak JF, Kronmal RA et al. (1999) Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Eng J Med 340: 14–22

    Google Scholar 

  • Ockene IS, Houston Miller N (1997) Cigarette smoking, cardiovascular disease, and stroke. Circulation 96: 3243–3247

    PubMed  CAS  Google Scholar 

  • Ogston B, Bennet NB, Ogston CM (1970) The influence of cigarette smoking on the plasma fibrinogen concentration. Atherosclerosis 11: 349–353

    Google Scholar 

  • Pate RP, Pratt M, Blair SN et al. (1995) Physical activity and public health: A recommendation from the Centers of Disease Control and Prevention and the American College of Sports Medicine. JAMA 273: 402–407

    Google Scholar 

  • Paul O, Lepper MJ, Phelan WH et al. (1963) A longitudinal study of coronary heart disease. Circulation 28: 20–31

    PubMed  CAS  Google Scholar 

  • Pearson T, Rapaport E, Criqui M et al. (1994) Optimal risk factor management in the patient after coronary revascularization: a statement for healthcare professionals from an American Heart Association Writing Group. Circulation 9o: 3125–3133

    Google Scholar 

  • Potter JF, Beevers DG (1984) Pressor effect of alcohol in hypertension. Lancet I: 119–122

    Google Scholar 

  • Powell KE, Thompson PD, Caspersen CJ, Ford ES (1987) Physical activity and the incidence of coronary heart disease. Annu Rev Public Health 8: 253–287

    Google Scholar 

  • Preedy VR, Richardson PJ (1996) Alcoholic cardiomyopathy: clini- cal and experimental pathological changes. Herz 21: 241–247

    PubMed  CAS  Google Scholar 

  • Prescott E,Hippe M,Schnohr P, Hein HO, Vestbo J (1998) Smoking and the risk of myocardial infarction in women and men: longitudinal population study. Br Med J 316: 1043–1047

    Google Scholar 

  • Psaty BM, Heckbert SR, Atkins D et al. (1994) The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. Arch Intern Med 154: 1333–1339

    PubMed  CAS  Google Scholar 

  • Puddey IB, Beilin LJ, Vandongen R, Rouse IL, Rogers P (1985) Evidence for a direct effect of alcohol consumption on blood pressure in normotensive men: a randomized controlled trial. Hypertension 7: 707–713

    PubMed  CAS  Google Scholar 

  • Puddey IB,Beiling LJ, Vandongen RJ (1987) Regular alcohol use raises blood pressure in treated hypertensive subjects. Lancet I: 647–651

    Google Scholar 

  • Rader DJ, Brewer B (1992) Lipoprotein(a): clinical approach to a unique atherogenic lipoprotein. JAMA 267: 1109–1112

    PubMed  CAS  Google Scholar 

  • Rader DJ, Hoeg JM, Brewer HBJ (1994) Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Ann Intern Med 120: 1012–1025

    PubMed  CAS  Google Scholar 

  • Randall B (1990) Sudden death and hepatic fatty metamorphosis: A North Carolina study. JAMA 1980/243: 1723

    Google Scholar 

  • Randin D, Vollenweider P, Tappy E et al. (1995) Suppression of alcohol-induced hypertension by dexamethasone. N Engl J Med 332 1733–1737

    Google Scholar 

  • Regan TJ (1990) Alcohol and the cardiovascular system. JAMA 264: 377–381

    Google Scholar 

  • Reid DD, Hamilton PJS, McCartney P, Rose G (1976) Smoking and other risk factors for coronary heart disease in British civil servants. Lancet II: 979–984

    Google Scholar 

  • Renaud S, Guéguen J, Schenker A, d’Houtaud A (1998) Alcohol and mortality in middle-aged men from eastern France. Epidemiology 9: 184–188

    PubMed  CAS  Google Scholar 

  • Renaud S, Lorgeril M de (1992) Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 339: 1523–1526

    PubMed  CAS  Google Scholar 

  • Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336: 973–979

    Google Scholar 

  • Rimm EB, Giovannucci EL, Willet WC et al. (1991) Propective study of alcohol consumption and risk of coronary disease in men. Lancet 338: 464–468

    PubMed  CAS  Google Scholar 

  • Roberts WC, Siegel RJ, McManus BM (1987) Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients. Am J Cardiol 60: 1340–1355

    PubMed  CAS  Google Scholar 

  • Rosengren A, Wilhelmsen L, Eriksson E et al. (1990) Lipoprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle-aged men. BMJ 301: 1248–1251

    PubMed  CAS  Google Scholar 

  • Rosengren A, Wilhelmsen L, Wedel H (1988) Separate and combined effects of smoking and alcohol abuse in middle-aged men. Acta Med Scand 223: m-118

    Google Scholar 

  • Ross R (1993) The pathogenesis of atherosclerosis. A perspective for the 1990’s. Nature 362: 801

    PubMed  CAS  Google Scholar 

  • Ross R, Glomset JA (1973) Atherosclerosis and the arterial smooth muscle cell. Science 180: 1332

    PubMed  CAS  Google Scholar 

  • Rubins HB, Robins SJ, Collins D et al. (1995) Distribution of lipid in 8500 men with coronary artery disase. Am J Cardiol 75: 1196–1201

    PubMed  CAS  Google Scholar 

  • Ruilope LM (1995) Effects of angiotensin converting enzyme inhibitors on the progression of diabetic nephropathy. J Hypertens 2 [Supp113]: 91–93

    Google Scholar 

  • Rupp H, Brilla CG, Maisch B (1996) Hypertonie and Alkohol: zentrale and periphere Mechanismen. Herz 258–264

    Google Scholar 

  • Sachinidis A, Locher R, Vetter W (1991) Generation of intracellular signals by low density lipoprotein is independent of the classical LDL receptor. Am J Hypertens 4: 274–279

    Google Scholar 

  • Sachinidis A, Mendgen T, Locher R, Brunner C, Vetter W (1990) Novel activities for low densitiy lipoprotein in vascular smooth muscle cells. Hypertension 15: 704–711

    PubMed  CAS  Google Scholar 

  • Sacks FM, Moyé LA, Davis BR et al. (1998) Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the cholesterol and recurrent events trial. Circulation 97: 1446–1452

    PubMed  CAS  Google Scholar 

  • Sacks FM, Pfeffer MA, Moyé LA et al. for the Cholesterol, and Recurrent Events Trial Investigators (1996) The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335: 1001–1009

    Google Scholar 

  • Sandholzer C, Boerwinkle E, Saha N, Tong MC, Utermann G (1992) Apolipoprotein(a) phenotypes. Lp(a) concentration and plasma lipid levels in relation to coronary heart diesease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. J Clin Invest 89: 1040–1046

    PubMed  CAS  Google Scholar 

  • Sangiorgi G, Rumberger JA, Severson A et al. (1998) Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 31: 126–133

    PubMed  CAS  Google Scholar 

  • Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4 S). Lancet 344: 1383–1389

    Google Scholar 

  • Scandinavian Simvastatin Survival Study Group (1995) Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study Group (4 S) Lancet 345: 1274–1275

    Google Scholar 

  • Scandinavian Simvastatin Survival Study Group (1998) Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study Group (4 S). Circulation 97: 1453–1460

    Google Scholar 

  • Schunkert H, Danser AH, Hense HW et al. (1997) Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 95: 39–45

    Google Scholar 

  • Schwartz F, Mall G, Zebe H et al. (1984) Determinants of survival in patients with congestive cardiomyopathy: quantitative morphologic findings and left ventricular hemodynamics. Circulation 70: 923–928

    Google Scholar 

  • Second joint task force of European and other societies on coronary prevention (1998) Prevention of coronary heart disease in clinical practice. Eur Heart 119: 1434–1503

    Google Scholar 

  • Sempos CT, Cleeman JI, Carroll MD et al. (1993) Prevalence of high blood cholesterol among US adults: an update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel. JAMA 23: 3009–3014

    Google Scholar 

  • Sempos CT, Looker AC, Gillum RF (1996) Iron and heart disease: the epidemiologic data. Nutr Rev 54: 73–84

    Google Scholar 

  • SHEP Cooperative Research Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the systolic hypertension in the elderly program (SHEP). JAMA 265: 3255–3264

    Google Scholar 

  • Shwaery GT Vita JA, Keaney JF (1997) Antioxidant Protection of LDL by Physiological Concentrations of 1713-Estradiol. Requirement for Estradiol Modification. Circulation 95: 1378–1385

    Google Scholar 

  • Siddiy T, Richardson PJ, Mitchell WD, Teare J, Preedy VR (1993) Ethanol-induced inhibition of ventricular protein synthesis in vivo and the possible role of acetaldehyde. Cell Biochem Funct 11: 45–54

    Google Scholar 

  • Sidney S, Petitti DB, Quesenberry CP Jr (1997) Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women. Ann Intern Med 127: 504–508

    Google Scholar 

  • Sigurdsson G Jr, Gudnason V, Sigurdsson G, Humphries SE (1992) Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of HDL and apo A-I. Arterioscler Thromb 12: 1017–1022

    PubMed  CAS  Google Scholar 

  • Sigurdsson G, Baldursdottir A, Sigvaldason H et al. (1992) Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. Am J Cardiol 69: 1251–1254

    PubMed  CAS  Google Scholar 

  • Silagy C, Mant D, Fowler G, Lodge M (1994) Meta-analysis of efficacy of nicotine replacement therapies in smoking cessation. Lancet 343: 139–142

    PubMed  CAS  Google Scholar 

  • Sjöström L, Rissanen A, Andersen T et al. for the European Multicentre Orlistat Study Group (1998) Randomised placebo-controlled trial of orlistat for weight loss and prevention of weigth regain in obese patients. Lancet 352: 167–173

    Google Scholar 

  • Staessen JS, Fagard R, Thijs L for the Systolic Hypertension-Europe (Syst-Eur) Trial Investigators (1997) Morbidity and mortality in the placebo-controlled European Trial on Isolated Hypertension in the Elderly. Lancet 360: 757–764

    Google Scholar 

  • Stamler J, Neaton JD, Wentworth DN (1989) Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension 13 [Suppl I]: 2–12

    Google Scholar 

  • Stamler J, Rhomberger P, Schoenberger JA et al. (1975) Multivariate analysis of the relationship of seven variabels to blood pressure. Findings of the Chicago Heart Association Detection Project in Industry, 1967–1972. J Chron Dis 28: 527–548

    Google Scholar 

  • Stamler J, Wentworth D, Neaton JD (1986) Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356.222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT) JAMA 256: 2823–2828

    PubMed  CAS  Google Scholar 

  • Stamler J, Wentworth D, Neaton JD for the MRFTI Research Group (1986) Is the relationship between serum cholestol and risk of premature death from coronary heart disease continuous and graded? Findings in 356.222 primary screenees of the Multiple Risk Factor Intervention Trial ( MRFIT ). JAMA 256: 2823–2828

    Google Scholar 

  • Stampfer MJ, Colditz GA (1991) Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prey Med zo: 47–63

    Google Scholar 

  • Stokes J, Kannel WB, Wolf PA, Guppies LA, D’Agosting RB (1987) The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old. 3o years of follow-up in the Framingham study. Circulation 75 [Suppl V]: V - 65

    Google Scholar 

  • Stone NJ (1998) Diet nutritional issues, and obesity. In: Topol EJ (ed) Textbook of Cardiovascular Medicine. Lippincott-Raven, Philadelphia

    Google Scholar 

  • Strauer BE, Motz W, Schwartzkopff B et al. (1994) The heart in hypertension. In: Swales JD (ed) Textbook of hypertension. Blackwell, Oxford

    Google Scholar 

  • Sugiishi M, Takatsu F (1993) Cigarette smoking is a major risk factor for coronary spasm. Circulation 87: 76–79

    PubMed  CAS  Google Scholar 

  • Sullivan JM, El-Zeky F, Vander Zwaag R, Ramanathan KB (1997) Effect on survival of estrogen replacement therapy after coronary artery bypass grafting. Am J Cardiol 79: 847–850

    PubMed  CAS  Google Scholar 

  • Sullivan JM, Vander Zwaag R, Hughes JP et al. (1990) Estrogen replacement and coronary artery disease. Arch Intern Med 150: 2557–2562

    PubMed  CAS  Google Scholar 

  • Tamura A, Watanabe T, Mikuriya Y, Nasu M (1995) Serum lipoprotein(a) concentrations are related to coronary disease progression without new myocardial infarction. Br Heart J 74: 365–369

    PubMed  CAS  Google Scholar 

  • Tarashi TP, Rubin E (1985) Effects of ethanol on the chemical and structural properties of biological membranes. Lab Invest 52: 120–131

    Google Scholar 

  • Tatti P, Pahor M, Byington RP et al. (1998) Outcome results of the fosinopril vs. amlodipine cardiovascular events randomized trial ( FACET) in patients with hypertension and NIDDM. Diabetes Care 21: 597–603

    Google Scholar 

  • Taylor JR, Combs-Orne T (1985) Alcohol and strokes in young adults. Am J Psychiatry 142: u6–118

    Google Scholar 

  • Terres W, Tatsis E, Pfalzer B et al. (1995) Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a). Circulation 91: 948–950

    Google Scholar 

  • Thaulow E, Erikssen J, Sandvik L et al. (1991) Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 84: 613–617

    PubMed  CAS  Google Scholar 

  • The Expert Commitee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the Expert Commitee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20: 1183–1197

    Google Scholar 

  • The Lipid Research Clinic Coronary Primary Prevention Trial results (1984) I: Reduction in incidence of coronary heart disease. JAMA 251: 351–364

    Google Scholar 

  • Thijs L, Fagard R, Lijnen P et al. (1992) A meta-analysis of outcome trials in elderly hypertensives. J Hypertens lo: 1103–1109

    Google Scholar 

  • Thomas G, Aider B, Oldewurtel HA et al. (1980) Am J Cardiol 46: 233–241

    Google Scholar 

  • Thompson SG, Kienast J, Pyke SDM et al. (1995) Hemostatic factors and the risk of myocardial infarction of sudden death in patients with angina pectoris. N Eng J Med 332: 635–641

    Google Scholar 

  • Thun MJ, Peto R, Lopez AD et al. (1997) Alcohol consumption and mortality among middle aged and elderly US adults. N Engl J Med 337: 1705–1714

    Google Scholar 

  • Trip MD, Cats VM, Capelle FJI van, Vrecken J (1990) Platelet hyper-reactivity and prognosis in survivors of myocardial infarction. N Engl J Med 322: 1549–1554

    Google Scholar 

  • Tsai JC, Wang H, Perrella MA et al. (1996) Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest 97: 146–153

    Google Scholar 

  • Tschoepe D, Roesen P (1998) Heart disease in diabetes mellitus: A challenge for early diagnosis and intervention. Exp Clin Endocrinol Diabetes 106: 16–24

    Google Scholar 

  • Tuomainen TP, Punnonen K, Nyyssonen K, Salonen JT (1998) Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 97 /15: 1461–1466

    PubMed  CAS  Google Scholar 

  • Ubbink JB, Vermaak WJH, Merve A van der, Becker PJ (1993) Vitamin B-12, vitamin B-6, folate nutritional status in men with hypercysteinemia. Am J Clin Nutr 57: 47–53

    Google Scholar 

  • UK Prospective Diabetes Study Group (1998a) Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 317: 713–720

    Google Scholar 

  • UK Prospective Diabetes Study Group (1998b) Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ 317: 720–726

    Google Scholar 

  • UK Prospective Diabetes Study Group (1998c) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317: 703–712

    Google Scholar 

  • Unger RH, Foster DW (1997) Diabetes mellitus. In: Wilson JD, Foster DW (eds) Williams’ Textbook of Endocrinology, 9th edn. Saunders, Philadelphia, in press

    Google Scholar 

  • Urbano-Marquez A, Estruch R, Navarro-Lopez F et al. (1989) The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med 320: 409–415

    PubMed  CAS  Google Scholar 

  • Valentine RJ, Grayburn PA, Vega GL, Gruny SM (1994) Lp(a) lipoprotein is an independent, discriminating risk factor for premature peripheral atherosclerosis among white men. Arch Intern Med 154: 801–806

    Google Scholar 

  • Vandongen R, Puddey IB (1994) Alcohol intake and blood pressure. In: Swales JD (ed) Textbook of hypertension. Blackwell, Oxford

    Google Scholar 

  • Vikhert AM, Tsiplenkova VG, Cherpachenko NM (1986) Alcoholic cardiomiyopathy and sudden cardiac death. J Am Coll Cardiol 8 [Suppl 8J: 3A - 11A

    CAS  Google Scholar 

  • Währborg P (1998) Mental stress and ischemic heart disease: an un- derestimated connection. Eur Heart J 19 [Suppl O[: 020–023

    Google Scholar 

  • Walsh BW, Kuller LH, Wild RA et al. (1998) Effects of raloxifene on serum lipids and coagulation factors in healty postmenopausal women. JAMA 279: 1445–1451

    PubMed  CAS  Google Scholar 

  • Wang XL, Liu S-X, Wilcken DEL (1997) Circulating transforming growth factor ßl and coronary artery disease. Cardiovasc Res 34: 404–410

    Google Scholar 

  • Wannamethee G, Shaper AG (1992) Alcohol and sudden cardiac death. Br Heart J 68: 443–448

    Google Scholar 

  • Warshafsky S, Kramer RS, Sivak SL (1993) Effect of garlic on total serum cholesterol: a meta-analysis. Ann Intern Med 119: 599–605

    Google Scholar 

  • Waßmann S, Nickenig G, Böhm M (1998) HMG-CoA reductase inhibitor atorvastatin downregulates ATi receptor gene expression and cell proliferation in vascular smooth muscle cells. Kid Blood Pressure Res 21 /5: 392

    Google Scholar 

  • Watson KE, Abrolat ML, Malone LL et al. (1997) Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 96: 1755–1760

    PubMed  CAS  Google Scholar 

  • Webber LS, Voors AW, Sriniviasan SR et al. (1979) Occurence in children of multiple risk factors for coronary artery disease: the Bogalusa heart study. Prey Med 8: 407–418

    CAS  Google Scholar 

  • Weinsier RL, Hunter GR, Heini AF, Goran MI, Sell SM (1998) The etiology of obesity: relative contribution of metabolic factors, diet, and physical activity. Am J Med 105: 145–150

    PubMed  CAS  Google Scholar 

  • Welch GN, Loscalzo J (1998) Homocystein and atherothrombosis. N Engl J Med 338: 1042–1050

    PubMed  CAS  Google Scholar 

  • West of Scotland Coronary Prevention Study Group (1992) A coronary primary prevention study of Scottish men age 45–64 years: trial design. J Clin Epidemiol 45: 849–860

    Google Scholar 

  • West of Scotland Coronary Prevention Study Group (1995) Screening experience and baseline characteristics in the West of Scotland Coronary Prevention Study. Am J Cardiol 76: 485–491

    Google Scholar 

  • West of Scotland Coronary Prevention Study Group (1997) Baseline risk factors and their association with outcome in the West of Scotland Coronary Prevention Study. Am J Cardiol 74: 756–762

    Google Scholar 

  • West of Scotland Coronary Prevention Study Group (1998) Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 97: 1440–1445

    Google Scholar 

  • White CR, Shelton J, Chen S et al. (1997) Estrogen restores endothelial cell funcion in an experimental model of vascular injury. Circ 96: 1624–1630

    CAS  Google Scholar 

  • WHO scientific group (1994) Cardiovascular disease risk factors: new areas for research. WHO Technical Report Series 841. World Health Organization, Geneva

    Google Scholar 

  • Williams JK, Honore EK, Adams MR (1997) Contrasting effects of conjugated estrogens and Tamoxifen on dilator responses of atherosklerotic epicardial coronary arteries in nonhuman primates. Circulation 96: 1970–1975

    Google Scholar 

  • Willich SN, Lewis M, Lowel H et al. (1993) Physical exertion as a trigger of acute myocardial infarction. N Engl J Med. 329: 1684–1690

    PubMed  CAS  Google Scholar 

  • Willms B (1997) Insulintherapie des Typ-I-Diabetes. Wien Med Wochenschr 147: 206–210

    PubMed  CAS  Google Scholar 

  • Wilson PF, Kannel WB (1995) Hypertension, other risk factors, and the risk of cardiovascular disease. In: Laragh LH, Brenner BM (eds) Hypertension. Pathophysiology, Diagnosis and Management. Raven Press, New York, pp 99–114

    Google Scholar 

  • Wood D, DeBacker G, Faergeman O et al. (1998) Prevention of coronary heart disease in clinical practice. Eur Heart J 19: 1434–1503

    Google Scholar 

  • Wood PD, Terry RB, Haskell WL (1985) Metabolism of substrates: Diet, lipoprotein metabolism and exercise. Federation Proceedings 44: 358–363

    Google Scholar 

  • Yla-Herttuala S (1996) Expression of lipoprotein receptors and related molecules in atherosclerotic lesions. Curr Opin Lipidol 7 /5: 292–297

    PubMed  CAS  Google Scholar 

  • Zenker G, Költringer P, Bone G et al. (1986) Lipoprotein (a) as a strong indication for cerebrovascular disease. Stroke 17: 942–945

    PubMed  CAS  Google Scholar 

  • Zhang Y, Proenca R, Maffei M et al. (1994) Positional cloning of the mouse ob gene and its human homologue. Nature (London) 372: 425–432

    CAS  Google Scholar 

Download references

Authors
  1. M. Böhm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Diet
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Flesch
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. U. Laufs
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Nickenig
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. P. Schnabel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medizinische Klinik III, Universität zu Köln, Joseph-Stelzmann-Straße 9, 50924, Köln, Deutschland

    Erland Erdmann

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Böhm, M., Diet, F., Flesch, M., Laufs, U., Nickenig, G., Schnabel, P. (2000). Fettstoffwechsel, Übergewicht und Ernährung, Diabetes. In: Erdmann, E. (eds) Klinische Kardiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-12156-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-12156-6_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-12157-3

  • Online ISBN: 978-3-662-12156-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation